Schmelter, F., Föh, B., Mallagaray, A., Rahmöller, J., Ehlers, M., Lehrian, S., . . . Günther, U. L. (2021). Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients. Frontiers in molecular biosciences, 8, 737039. https://doi.org/10.3389/fmolb.2021.737039
Chicago Style (17th ed.) CitationSchmelter, Franziska, et al. "Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients." Frontiers in Molecular Biosciences 8 (2021): 737039. https://doi.org/10.3389/fmolb.2021.737039.
MLA (9th ed.) CitationSchmelter, Franziska, et al. "Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients." Frontiers in Molecular Biosciences, vol. 8, 2021, p. 737039, https://doi.org/10.3389/fmolb.2021.737039.